Effectiveness of Cervical Testing in and outside a Screening Program—A Case-Control Study
Open Access
Abstract
In many countries with organized cervical cancer screening, opportunistic Pap and human papillomavirus (HPV) tests are common. However, little is known about their effectiveness. We examined the effect of testing in and outside the Finnish screening program on the risk of cervical cancer. We conducted a case-control study that involved 1677 cases with invasive cervical cancer that were diagnosed between 2010 and 2019. Five- and three-year test intervals were analyzed across all ages, by age group and by cancer morphology subtype. Conditional logistic regression was used, adjusting for socioeconomic variables. Women undergoing any kind of cervical test had a significantly lowered risk of cervical cancer (adjusted OR = 0.43, 95% CI = 0.38–0.48, tests in five-year intervals). The results were similar, regardless of whether the test had been taken in the screening program or outside of it, or whether the interval was five years or three years. Testing of women at ages 35–64 showed the strongest effects, but moderate preventive effects were seen until age 79. No significant effect was seen below age 30. Tests in and outside the program were effective at the screening target age. However, participation in the program should be encouraged for optimal cost-effectiveness. Preventive effects were also seen above the program target ages.Keywords
Funding Information
- The Cancer Society of Finland
This publication has 42 references indexed in Scilit:
- Screening for cervical cancer: a systematic review and meta-analysisSystematic Reviews, 2013
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- The importance of socio-economic variables in cancer screening participation: A comparison between population-based and opportunistic screening in the EU-15Health Policy, 2011
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceThe Lancet Oncology, 2011
- European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary DocumentAnnals of Oncology, 2010
- Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening programInternational Journal of Epidemiology, 2010
- Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in SwedenJNCI: Journal of the National Cancer Institute, 2008
- An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical DysplasiaJNCI: Journal of the National Cancer Institute, 1995